PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32462874-7	2020	We complement the aforementioned immunohistochemical studies by quantitatively measuring lyso-PS concentrations in various brain regions using mass spectrometry and find that the cerebellar lyso-PS levels are most affected by deletion of ABHD16A (decreased) or ABHD12 (increased).	lysophosphatidylserine	190-197	abhydrolase domain containing 16A	Mus musculus	238-245	
25580854-5	2015	We describe a small-molecule inhibitor of ABHD16A that depletes lyso-PSs from cells, including lymphoblasts derived from subjects with PHARC.	lysophosphatidylserine	64-72	abhydrolase domain containing 16A	Mus musculus	42-49	
25580854-6	2015	In mouse macrophages, disruption of ABHD12 and ABHD16A respectively increases and decreases both lyso-PSs and lipopolysaccharide-induced cytokine production.	lysophosphatidylserine	97-105	abhydrolase domain containing 16A	Mus musculus	47-54	
25580854-7	2015	Finally, Abhd16a(-/-) mice have decreased brain lyso-PSs, which runs counter to the elevation in lyso-PS in Abhd12(-/-) mice.	lysophosphatidylserine	48-56	abhydrolase domain containing 16A	Mus musculus	9-16	
25580854-7	2015	Finally, Abhd16a(-/-) mice have decreased brain lyso-PSs, which runs counter to the elevation in lyso-PS in Abhd12(-/-) mice.	lysophosphatidylserine	48-55	abhydrolase domain containing 16A	Mus musculus	9-16	
25580854-8	2015	Our findings illuminate an ABHD16A-ABHD12 axis that dynamically regulates lyso-PS metabolism in vivo, designating these enzymes as potential targets for treating neuroimmunological disorders.	lysophosphatidylserine	74-81	abhydrolase domain containing 16A	Mus musculus	27-34